Business
Posting of notice of General Meeting
Posting of notice of General Meeting.
About this update from Edx Medical Group Plc
[{"type":"text","content":"\n\n \n \n \nEDX Medical Group plc: EDX\n17 June 2025\n \n\n17 June 2025\nEDX Medical Group plc\nAQSE: EDX\n(\"EDX Medical\" or the \"Group\" or \"Company\")\nPosting of Notice of General Meeting\nCAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that a general meeting will be held at the Heritage Centre, Royal School of Medicine, 2nd floor, 1 Wimpole St, Westminster, London, W1G 0AE on 3 July at 11am.\nThe Notice of General Meeting and Form of Proxy will be posted today, 17 June 2025, to eligible shareholders. Electronic copies will be shortly available on the Company's website at: https://edxmedical.co.uk/documents/\nContacts:\n \n\n\n\n\nEDX Medical Group plc\n\n\n\n\n\n\n\n\nDr Mike Hudson (Chief Executive Officer)\n\n\n+44 (0)7812 345 301\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOberon Capital\n\n\n\n\n\n\n\n\nNick Lovering (Corporate Adviser)\nAdam Pollock (Corporate Broking)\nMike Seabrook (Corporate Broking)\n\n\n+44 (0)20 3179 5300\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nIFC Advisory (Investor Relations)\n\n\n\n\n\n\n\nTim Metcalfe\n\n\n+44 (0)20 3934 6630\n\n\n\n\nGraham Herring\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMedia House International\n\n\n\n\n\n\n\n\nRamsay Smith\n \nGary McQueen\n\n\n+44 (0)7788 414856\[email protected]\n+ 44 (0)7834 694609\[email protected]\n\n\n\n\n \nNotes for Editors:\nAbout EDX Medical Group\nEDX Medical Group Plc is listed on the Apex Segment of the AQSE Growth Market (TIDM: EDX).\nEDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson.\nBy translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost effectively improve the detection and characterisation of disease in order to personalise treatment in a timely fashion. Early disease detection and biologically-based personal treatment optimisation is considered to be the most impactful way of reducing deaths and lowering the cost of healthcare globally.\nEDX Medical Group provides doctors, hospitals and insurers/payers with access to...